the second group ( 1973-1975 ) entered in a g.a.t.l.a . protocol consisting of : vincristine-prednisone plus surgery and/or radiotherapy as induction treatment , craniocervical radiotherapy and intrathecal methotrexate as cns preventive treatment and anti-leukemia ( 6-mercaptopurine , methotrexate and vincristine-prednisone pulses ) or anti-lymphoma ( copp ) treatment as maintenance , in a randomized trial .
C0032952
prednisone
C0056286
copp